Year-over-year earnings per share growth for the last twelve months: Bluejay Diagnostics (BJDX)
Bluejay Diagnostics (BJDX) dominates the urgent sepsis diagnostics segment thanks to its Symphony platform. The current quarterly EPS trend illustrates this market position, where 80.00 determines this parameter level. The company attracts leading scientists due to the high significance of its developments. However, slow FDA approval and capital shortages create risks of share dilution.
BJDX (Bluejay Diagnostics Corp): analytical breakdowns and indicator data
- share price and expert price forecast:
- company stock exchange capitalization indicators:
- book capitalization data:
- debt level and financial liquidity data:
Total Debt to Equity Ratio Bluejay Diagnostics|BJDX - Long-Term Debt to Capital|Short-Term Debt to Capital Bluejay Diagnostics|BJDX - Company Cumulative Debt|Debt to Book Capitalization Ratio Bluejay|BJDX - Amount of Long-Term Liabilities|Company Short-Term Debts Bluejay Diagnostics|Quick Liquidity Indicator bluejaydx.com
- earnings and valuation multiples indicators:
BJDX - Company Net Income|Future Profit Bluejay Diagnostics|BJDX - Company Value to Net Income|Forward P/E Multiple Bluejay|BJDX - Growth-Adjusted P/E Ratio|EV/EBITDA Multiple Bluejay|BJDX - Operating income before deduction of amortization|Net earnings per share (EPS TTM) Bluejay Diagnostics|BJDX - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth bluejaydx.com|BJDX - Net earnings per share change in current year|Net earnings per share growth forecast for next year Bluejay Diagnostics
Comprehensive company analysis:Bluejay Diagnostics
Quarterly EPS growth measures the rate of change in net income per share, separating real returns from accounting adjustments to assess fundamental value. Analyzing the level of quarterly EPS dynamics allows for a comparison of financial results with the scaling of Bluejay Diagnostics (BJDX) autonomous Symphony AI analyzers, where profit growth confirms the commercial efficiency of implementing robotic sepsis diagnostics in medical centers.
Competitor analysis for Bluejay Diagnostics
A: Quarterly EPS earnings growth|DGX - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Illumina Corp|Exact Sciences Inc. (EXAS) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth RVTY|Year-over-year earnings per share growth for the last twelve months BIO (bio-rad.com)|Year-over-year earnings per share growth for the last twelve months Anbio NNNN|Sotera Health Corp - Year-over-year earnings per share growth for the last twelve months|QDEL: Year-over-year net earnings per share growth for the last 12 months|OPK - Quarterly EPS earnings growth|CDNA: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months maravai.com (MRVI)|Year-over-year earnings per share growth for the last twelve months Fulgent Genetics|LAB (Standard BioTools Inc) - Year-over-year earnings per share growth rate for the last twelve months|Quarterly EPS earnings growth CTKB|Quarterly EPS earnings growth OraSure Corp (OSUR)|Exagen - Year-over-year net earnings per share growth for the last 12 months|mdxhealth.com (MDXH) - Earnings per share growth in annualized terms for the last twelve months|LUCD: Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months PRE (Prenetics Global)|IMDX: Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months TRIB|PRPH (ProPhase Labs, Inc.) - Quarterly EPS earnings growth|ainos.com (AIMD) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth CODX|Quarterly EPS earnings growth Heart Test Laboratories, Inc. (HSCS)|Quarterly EPS earnings growth BMRA (Biomerica, Inc)|Net earnings per share growth for the trailing year Cardio Diagnostics Holdings Inc.|ONCO - Year-over-year earnings per share growth for the last twelve months|VRAX (viraxbiolabs.com) - Year-over-year earnings per share growth for the last 12 months|Aspira Women's Health Inc. (AWH) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months Accelerate Diagnostics Inc. (AXDX)|Year-over-year earnings per share growth for the last twelve months CENTOGENE|Enzo (ENZ) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months FRES (Fresh2 Group Limited)|Year-over-year earnings per share growth rate for the last twelve months GENE|Quarterly EPS earnings growth ME (23andMe)|Year-over-year net earnings per share change for the last twelve months Psychemedics Corp. (PMD)
